[PENDING]

STATE OF PERSONALIZED MEDICINE IN LIVER DISEASES

A Scientific Conference to Encourage the Development of Effective Treatments

Personalized medicine may offer liver disease patients treatment options that directly suit their needs, leading to better patient outcomes. Partnering with the Personalized Medicine Coalition, GLI will serve as a catalyst to bring together data and information, including the biomarkers for nonalcoholic steatohepatitis, or NASH, and hepatitis C genotyping, that could one-day be used to help encourage the development of personalized medicine solutions.